Aseptuva
Aseptuva is dedicated to improving patient care and saving lives through innovative Far-UVC technology designed to prevent hospital-acquired infections (HAI), reduce the burden on healthcare staff, and combat antimicrobial resistance (AMR). The company develops automated disinfection adaptors for microbial contamination control at catheter-entry sites, aiming to make healthcare safer, more efficient, and resilient against future challenges. Their mission is to elevate healthcare globally by fighting HAI, supporting health workers, and countering AMR.
Industries
Nr. of Employees
small (1-50)
Aseptuva
Weyermannsstrasse 36, 3008 Bern, Switzerland
Products
Automated disinfection adaptor using Far‑UVC
A hands‑free, plug‑and‑play adaptor that applies guided Far‑UVC light to catheter‑entry sites to reduce microbial contamination and biofilm formation.
Automated disinfection adaptor using Far‑UVC
A hands‑free, plug‑and‑play adaptor that applies guided Far‑UVC light to catheter‑entry sites to reduce microbial contamination and biofilm formation.
Services
Laboratory proof‑of‑concept and efficacy testing of disinfection approaches against bacterial and fungal species implicated in hospital‑acquired infections.
Planning and execution of usability testing with clinical staff and hospital workflows to refine device ergonomics and procedures.
Joint design, fabrication and testing projects with external research institutes and industry partners to advance device maturity.
Testing and selection of sustainable materials and development of manufacturing processes aligned with EU sustainability grants and requirements.
Laboratory proof‑of‑concept and efficacy testing of disinfection approaches against bacterial and fungal species implicated in hospital‑acquired infections.
Planning and execution of usability testing with clinical staff and hospital workflows to refine device ergonomics and procedures.
Joint design, fabrication and testing projects with external research institutes and industry partners to advance device maturity.
Testing and selection of sustainable materials and development of manufacturing processes aligned with EU sustainability grants and requirements.
Expertise Areas
- Infection prevention and control for indwelling devices
- Medical device R&D and prototyping
- Photonics and UVC disinfection technology
- Preclinical validation and usability/human factors
Key Technologies
- Far‑UVC disinfection technology
- Photonics and light‑source engineering
- In‑vitro microbiological efficacy testing
- Biocompatibility testing
News & Updates
Winning the Horizon Europe Framework Programme – Transforming Health and Care Systems (THCS) initiative supported by Innosuisse.
Winning the GBIP AMR Switzerland programme to join the AMR Conference in Basel and help bring new antimicrobial treatments and diagnostics to the market.
Meeting stakeholders, healthcare experts, and potential partners in several states, while evaluating potential sites for future US operations.
Winning the NIHR Invention for Innovation (i4i) Grant to conduct studies with hospitals, labs, and packaging companies.
Becoming one of the Top-20 winners of the MassChallenge 2024 program in Switzerland.
Winning the Venture Leaders Medtech program to travel to Boston and optimize the US market strategy.
Winning the Horizon Europe Framework Programme – Transforming Health and Care Systems (THCS) initiative supported by Innosuisse.
Winning the GBIP AMR Switzerland programme to join the AMR Conference in Basel and help bring new antimicrobial treatments and diagnostics to the market.
Meeting stakeholders, healthcare experts, and potential partners in several states, while evaluating potential sites for future US operations.
Winning the NIHR Invention for Innovation (i4i) Grant to conduct studies with hospitals, labs, and packaging companies.
Becoming one of the Top-20 winners of the MassChallenge 2024 program in Switzerland.
Winning the Venture Leaders Medtech program to travel to Boston and optimize the US market strategy.